MBG453 in Lower Risk MDS

NCT04823624 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped The trial closed early due to changes in support for the study drug.

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: MBG453

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]